COMMUNIQUÉS West-GlobeNewswire

The decisions of Latvijas Juras medicinas centrs JSC Annual Shareholders’ Meeting on June, 12, 2018.

12/06/2018 - 17:37

Latvia, 2018-06-12 17:37 CEST (GLOBE NEWSWIRE) -- The decisions of Latvijas Juras medicinas centrs JSC Annual Shareholders’ Meeting on June, 12, 2018. Member of the Board: Juris Imaks, phone: 29512492

Information concerning the total number of voting rights and shares

12/06/2018 - 17:31

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l' [...]

Informations relatives au nombre total de droits de vote et d'actions

12/06/2018 - 17:31

Informations relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du Code de commerce et l'article 223-16 du Règlement général de l'Autorité des Marchés Financiers Sanofi Société [...]

ReWalk Personal 6.0 Exoskeleton Added to the Official German List of Medical Aids

12/06/2018 - 16:33

This listing enables any medically qualified individual to obtain reimbursement for a ReWalk Personal 6.0 Exoskeleton through German Statutory Health Insurance Funds, which provide coverage for 90% of the German [...]

Correction: DRAFT RESOLUTIONS of Annual General Meeting of Shareholders of joint stock company “Grindeks” to be held on 26 June 2018

12/06/2018 - 15:48

Details of auditor specified. 1. Reports of Board, Supervisory Council, Audit Committee and statement of Sworn auditor To take notice of the reports of the Board, the Supervisory Council, the Audit Committee and the [...]

Cynata Reports Positive Six-Month Data from Cohort A in Phase 1 Trial of CYP-001 in GvHD

12/06/2018 - 15:38

MELBOURNE, Australia, June 12, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX:CYP) is pleased to announce positive safety and sustained overall survival [...]

Epistem management buy-out

12/06/2018 - 15:12

MANCHESTER, United Kingdom, June 12, 2018 (GLOBE NEWSWIRE) -- Epistem, the Manchester UK-based Contract Research Company, announces that following investment by Foresight Group it has completed a management buy-out (“ [...]

SAP Teams with Cognoa to Bridge Gap in Healthcare for Employees Raising Young Children

12/06/2018 - 15:03

By incorporating Cognoa into its family benefits program, SAP empowers employees to better support their children’s developmental growth during critical early childhood years PALO ALTO, Calif., June 12, 2018 (GLOBE [...]

American College of Rheumatology Urges HHS to Adopt Drug Policy Principles that Protect Health Care Access for Chronically Ill Americans

12/06/2018 - 14:38

Washington, D.C., June 12, 2018 (GLOBE NEWSWIRE) -- In response to the Trump Administration’s American Patients First drug pricing blueprint, the American College of Rheumatology – which represents more than 7,700 [...]

Galectin Therapeutics Inc. Announces New CEO

12/06/2018 - 14:32

NORCROSS, Ga., June 12, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Harold H. Shlevin, Ph.D., currently [...]

Marrone Bio Innovations’ Amplitude™ Biofungicide is Available for This Growing Season‘s Fight Against White Mold

12/06/2018 - 14:31

Amplitude™ Is an Effective New Tool For Controlling White Molds In Pulse, Root And Oilseed Crops and Soil Diseases In Large Acre Crops DAVIS, Calif., June 12, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. ( [...]

Daxor Corporation Appoints Kathryn A. Kornafel Vice President of Marketing and Commercial Development

12/06/2018 - 14:30

NEW YORK , June 12, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) , an innovative medical instrumentation and biotechnology company focused on blood volume measurement today announces the appointment of [...]

OpGen Presents Data at ASM Microbe 2018 Demonstrating High Accuracy of Acuitas® for Predicting Antibiotic Resistance in Urine Specimens

12/06/2018 - 14:30

90% accuracy data presented for rapid antibiotic resistance prediction using Acuitas AMR Gene Panel and Acuitas Lighthouse on urine clinical specimens Prospective clinical trial in Colombia demonstrates 57% improvement [...]

Diffusion Pharmaceuticals Announces Validation of European Patent for Oral Formulations of TSC

12/06/2018 - 14:30

CHARLOTTESVILLE, Va., June 12, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the life expectancy of [...]

FDA Grants Rare Pediatric Disease Designation to A4250; Albireo Eligible to Apply for Priority Review Voucher

12/06/2018 - 14:30

BOSTON, June 12, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the U.S. Food and Drug [...]

Yield Endurance Strategic Partner Closes on Loan of 100 Bitcoins

12/06/2018 - 14:30

JERSEY CITY, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Sport Endurance, Inc.’s (OTCQB:SENZ) wholly-owned subsidiary, Yield Endurance, Inc. (“Yield”), today announced that its strategic business partner, Madison Partners [...]

Stealth Mark to Provide Automated Platform Version of ActiveDuty Intelligence System

12/06/2018 - 14:30

HOFFMAN ESTATES, IL, June 12, 2018 (GLOBE NEWSWIRE) -- Wellness Center USA, Inc. (OTCQB: WCUI) today announced its wholly-owned subsidiary, StealthCo, Inc., dba Stealth Mark, has released plans to offer a specialized, [...]

Cytori Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering

12/06/2018 - 14:30

SAN DIEGO, June 12, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq:CYTX) ("Cytori"), today provided an informational update to stockholders regarding its proposed rights offering and the expected key dates [...]

Chiesi and Holostem Announce FDA Orphan Drug Designation for GPLSCD01 for treatment of Limbal Stem Cell Deficiency (LSCD)

12/06/2018 - 14:00

Investigational therapy uses individual patient’s own stem cells to potentially regenerate and repair damaged eye tissue CARY, N.C., June 12, 2018 (GLOBE NEWSWIRE) -- Chiesi USA (key-A-zee) , a specialty pharmaceutical [...]